Xeroderma pigmentosum group F
XPF

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 2 references describing 24 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Sun sensitivity integumentary 100 % 26010807 2015-08-12
Cerebellar atrophy nervous 100 % 9579555 2015-08-12
Cerebral atrophy nervous 100 % 9579555 2015-08-12
Ataxia nervous 100 % 9579555 2015-08-12
Chorea nervous 100 % 9579555 2015-08-12
Cognitive deficits nervous 100 % 9579555 2015-08-12
Cancer integumentary 50 % 26010807 2015-08-12
Cerebellar atrophy nervous 0 % 26010807 2015-08-12
Ataxia nervous 0 % 26010807 2015-08-12
Cerebral atrophy nervous 0 % 26010807 2015-08-12
Cognitive deficits nervous 0 % 26010807 2015-08-12
Chorea nervous 0 % 26010807 2015-08-12



List of references:


Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients.
Yukari Tofuku, Yoshimasa Nobeyama, Ryoichi Kamide, Shinichi Moriwaki, Hidemi Nakagawa,



The Journal of dermatology - Sep 2015



Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease.
A M Sijbers, P C van Voorst Vader, J W Snoek, A Raams, N G Jaspers, W J Kleijer,



The Journal of investigative dermatology - May 1998